THC (Tenet Healthcare Corporation New)
Insider Trading Activity
Every open-market purchase and sale reported by THC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Nadja West | Director | Sell | — | — |
| 2026-09-01 | Lisa Y Foo | EVP, Chief Operating Officer | Sell | — | — |
| 2026-08-31 | CECIL D HANEY | Director | G | — | — |
| 2026-08-26 | CECIL D HANEY | Director | Sell | — | — |
| 2026-08-26 | Saumya Sutaria | CEO | Sell | — | — |
| 2026-08-10 | Tammy Romo | Director | Sell | — | — |
| 2026-08-07 | Roy Blunt | Director | Sell | — | — |
| 2026-08-07 | Roy Blunt | Director | Sell | — | — |
| 2026-07-31 | Lisa Y Foo | EVP, Chief Operating Officer | Sell | — | — |
| 2026-07-28 | JAMES L BIERMAN | Director | Sell | — | — |
| 2026-07-28 | Christopher S. Lynch | Director | Sell | — | — |
| 2026-07-28 | Paola M Arbour | EVP, Chief Information Officer | Sell | — | — |
| 2026-05-29 | J ROBERT KERREY | Director | Sell | — | — |
| 2026-05-28 | Meghan Fitzgerald | Director | A | — | — |
| 2026-05-28 | J ROBERT KERREY | Director | A | — | — |
| 2026-05-28 | Christopher S. Lynch | Director | A | — | — |
| 2026-05-28 | Tammy Romo | Director | A | — | — |
| 2026-05-28 | JAMES L BIERMAN | Director | A | — | — |
| 2026-05-28 | CECIL D HANEY | Director | A | — | — |
| 2026-05-28 | RICHARD W FISHER | Director | A | — | — |
| 2026-05-28 | Nadja West | Director | Sell | — | — |
| 2026-05-28 | RICHARD J MARK | Director | A | — | — |
| 2026-05-28 | Roy Blunt | Director | A | — | — |
| 2026-05-28 | Vineeta Agarwala | Director | A | — | — |
| 2026-05-26 | Roy Blunt | Director | MIXED | — | — |
| 2026-05-26 | J ROBERT KERREY | Director | MIXED | — | — |
| 2026-05-26 | RICHARD J MARK | Director | MIXED | — | — |
| 2026-05-26 | CECIL D HANEY | Director | MIXED | — | — |
| 2026-05-26 | Vineeta Agarwala | Director | M | — | — |
| 2026-05-26 | Meghan Fitzgerald | Director | MIXED | — | — |
| 2026-05-26 | RICHARD W FISHER | Director | MIXED | — | — |
| 2026-05-26 | Tammy Romo | Director | MIXED | — | — |
| 2026-05-26 | Nadja West | Director | MIXED | — | — |
| 2026-05-26 | Christopher S. Lynch | Director | M | — | — |
| 2026-05-26 | JAMES L BIERMAN | Director | M | — | — |
| 2026-03-13 | Paola M Arbour | EVP, Chief Information Officer | Sell | — | — |
| 2026-03-10 | Thomas W Arnst | EVP, Chief Admin. Officer & GC | Sell | — | — |
| 2026-03-03 | Thomas W Arnst | EVP, Chief Admin. Officer & GC | MIXED | — | — |
| 2026-03-03 | R. Scott Ramsey | Principal Accounting Officer | MIXED | — | — |
| 2026-03-03 | Lisa Y Foo | EVP, Chief Operating Officer | MIXED | — | — |
| 2026-03-03 | Paola M Arbour | EVP, Chief Information Officer | MIXED | — | — |
| 2026-03-03 | Sun Park | EVP & Chief Financial Officer | MIXED | — | — |
| 2026-03-03 | Saumya Sutaria | CEO | MIXED | — | — |
| 2026-02-26 | R. Scott Ramsey | Principal Accounting Officer | M | — | — |
| 2026-02-26 | Thomas W Arnst | EVP, Chief Admin. Officer & GC | M | — | — |
| 2026-02-26 | Lisa Y Foo | EVP, Chief Operating Officer | M | — | — |
| 2026-02-26 | Paola M Arbour | EVP, Chief Information Officer | M | — | — |
| 2026-02-26 | Saumya Sutaria | CEO | M | — | — |
| 2026-02-26 | Sun Park | EVP & Chief Financial Officer | M | — | — |
| 2026-02-18 | Nadja West | Director | G | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 16,228,420 | — |
| — | 10%+ Owner | 10,645,320 | — |
| — | Chairman and CEO | 1,110,712 | — |
| — | CEO | 533,993 | — |
| — | Former EVP & CFO | 474,912 | — |
| — | Former Executive Chairman | 466,018 | — |
| — | Vice Chairman | 336,877 | — |
| — | Director | 94,341 | — |
| — | Director | 76,228 | — |
| — | Senior Vice President | 74,330 | — |
| — | Director | 63,139 | — |
| — | Pres. of Hospital Operations | 60,066 | — |
| — | Director | 59,071 | — |
| — | Director | 47,138 | — |
| — | Pres. of Hospital Operations | 44,206 | — |
| — | Director | 35,614 | — |
| — | Director | 31,604 | — |
| — | Director | 29,868 | — |
| — | Director | 28,889 | — |
| — | Director | 28,284 | — |
| — | Director | 27,790 | — |
| — | Director | 23,889 | — |
| — | Director | 23,653 | — |
| — | SVP and General Counsel | 21,235 | — |
| — | Director | 20,473 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the THC quote page; the site-wide leaderboard is on the insider transactions hub.